Fig. 3From: New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label studyChanges in mean levels of serum indoxyl sulfate from baseline to 8 weeks after OSCA treatment. Abbreviation: OSCA, oral spherical carbon adsorbentBack to article page